Back to ATH-Increasing revenues
-Stable margins
Big upside potential in a soon to be, very big technology driven market.
−0.260 EUR
−4.31 M EUR
25.15 M EUR
20.10 M
About FACEPHI BIOMETRIA, S.A.
Sector
Industry
CEO
Javier Mira Miró
Website
Headquarters
Alicante
Founded
2012
ISIN
ES0105029005
FIGI
BBG006R5KWP5
Facephi Biometría SA is a technology company, which engages in the development and marketing of facial recognition software. It specializes in digital identity protection and verification, noted for its focus on data security and integrity. The firm offers inPhinite, a combination of biometric and other security systems that creates a complete digital onboarding and identity authentication solution that allows to access, verify, and operate different services and products in mobile and web applications. The company was founded by Javier Mira Miro on September 26, 2012 and is headquartered in Alicante, Spain.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FACE is 1.685 EUR — it has increased by 0.60% in the past 24 hours. Watch FACEPHI BIOMETRIA, S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange FACEPHI BIOMETRIA, S.A. stocks are traded under the ticker FACE.
FACE stock has risen by 7.32% compared to the previous week, the month change is a 11.59% rise, over the last year FACEPHI BIOMETRIA, S.A. has showed a −27.37% decrease.
We've gathered analysts' opinions on FACEPHI BIOMETRIA, S.A. future price: according to them, FACE price has a max estimate of 2.10 EUR and a min estimate of 2.10 EUR. Watch FACE chart and read a more detailed FACEPHI BIOMETRIA, S.A. stock forecast: see what analysts think of FACEPHI BIOMETRIA, S.A. and suggest that you do with its stocks.
FACE reached its all-time high on Feb 19, 2020 with the price of 9.100 EUR, and its all-time low was 0.290 EUR and was reached on Dec 17, 2015. View more price dynamics on FACE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
FACE stock is 5.62% volatile and has beta coefficient of 0.60. Track FACEPHI BIOMETRIA, S.A. stock price on the chart and check out the list of the most volatile stocks — is FACEPHI BIOMETRIA, S.A. there?
Today FACEPHI BIOMETRIA, S.A. has the market capitalization of 37.77 M, it has decreased by −1.27% over the last week.
Yes, you can track FACEPHI BIOMETRIA, S.A. financials in yearly and quarterly reports right on TradingView.
FACE net income for the last half-year is −6.29 M EUR, while the previous report showed 385.51 K EUR of net income which accounts for −1.73 K% change. Track more FACEPHI BIOMETRIA, S.A. financial stats to get the full picture.
No, FACE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 264.00 employees. See our rating of the largest employees — is FACEPHI BIOMETRIA, S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FACEPHI BIOMETRIA, S.A. EBITDA is −1.27 M EUR, and current EBITDA margin is −3.75%. See more stats in FACEPHI BIOMETRIA, S.A. financial statements.
Like other stocks, FACE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FACEPHI BIOMETRIA, S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FACEPHI BIOMETRIA, S.A. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FACEPHI BIOMETRIA, S.A. stock shows the sell signal. See more of FACEPHI BIOMETRIA, S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.